Experienced medtech executive Sue MacLeman appointed to board of Planet Innovation

Latest News

Melbourne-based healthtech innovation and commercialisation company Planet Innovation has appointed the current chair of MTPConnect Sue MacLeman to its board.

Ms MacLeman has more than three decades of experience as a pharmaceutical, biotechnology and medical technology executive. She has served as CEO and a board member of several ASX and NASDAQ listed companies.

In addition to chairing MTPConnect, Ms MacLeman is also chair of ASX-listed Anatara Lifesciences, Tali Digital and Oventus Medical. She is also a non-executive director of Palla Pharma and veski.

In addition to the board memberships, Ms MacLeman is appointed to several academic and government advisory boards including the Prime Minister’s Digital Expert Advisory Board, CSIRO Health and Biosecurity Advisory Committee, Genomics Health Futures Mission Expert Advisory Committee and a number of COVID-19 taskforces.

“I have always been impressed with the PI team’s ambition, high performance and willingness to back themselves. They have continued to successfully execute on their strategy to leverage their core design capability to drive revenue and value. The repeat business from global and local clients is a testament to the work they do and value they bring to the customer,” said Ms MacLeman.

“It is always wonderful to work with high performing teams and I am looking forward to using my skills and expertise to assist PI as they continue to scale globally.”

Planet Innovation CEO Stuart Elliott said the appointment further strengthens its board.

Sue brings a wealth of experience directly relevant to the PI mission, including an impressive track record in executive and board roles in a range of medtech and biotech companies. Sue has strong expertise in the public markets and M&A, and many connections to key stakeholders in the healthtech ecosystem globally,” said Mr Elliott.

“Her expertise is highly complementary to the existing PI Board and we are excited to have access to Sue’s insights to help guide the business during the growth period that we have ahead of us.”